These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6624711)

  • 1. Effects of Fluosol-DA (artificial blood) on clinical chemistry tests and instruments.
    Mullins RE; Hutton PS; Conn RB
    Am J Clin Pathol; 1983 Oct; 80(4):478-83. PubMed ID: 6624711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma enzyme concentrations in response to blood substitution with perfluorocarbon emulsion in the conscious rat.
    Lowe KC; McNaughton DC
    Experientia; 1986 Dec; 42(11-12):1228-31. PubMed ID: 3780945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit.
    Shrewsbury RP; White LG
    Clin Chim Acta; 1989 Feb; 179(3):347-8. PubMed ID: 2714008
    [No Abstract]   [Full Text] [Related]  

  • 4. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in intravascular fluid composition following blood replacement with perfluorocarbon emulsion in the rat.
    Lowe KC; McNaughton DC; Hardy RN
    Klin Wochenschr; 1985 Oct; 63(19):1028-34. PubMed ID: 4068605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive transfusion of perfluorocarbon emulsion (Fluosol-DA) in newborn piglets.
    Hall JE; Karlson KH; DuRant RH
    Dev Pharmacol Ther; 1987; 10(3):163-73. PubMed ID: 3608746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Fluosol-DA on radioimmunoassay results.
    Hammarstrom M; Mullins R; Sgoutas D
    Clin Chem; 1983 Jul; 29(7):1418-21. PubMed ID: 6861348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissue and immunological competence.
    Bollands AD; Lowe KC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):309-12. PubMed ID: 2879690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased infection mortality and decreased neutrophil migration due to a component of an artificial blood substitute.
    Lane TA; Lamkin GE
    Blood; 1986 Aug; 68(2):351-4. PubMed ID: 3524707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of varying extents of Fluosol-DA or normal saline haemodilution on the dose dependent kinetics of phenytoin in the rat.
    Shrewsbury RP; Oliver SR; Lewis LM; Anderson WT; White LG
    J Pharm Pharmacol; 1989 Aug; 41(8):582-4. PubMed ID: 2571710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute responses during blood substitution in the conscious rat.
    Hardy RN; Lowe KC; McNaughton DC
    J Physiol; 1983 May; 338():451-61. PubMed ID: 6875966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perfluorochemical emulsion as an oxygen carrier.
    Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion.
    Gennaro M; Mohan C; Ascer E
    Cardiovasc Surg; 1996 Jun; 4(3):399-404. PubMed ID: 8782946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
    Madjidi A; Beisbarth H; Frey R
    Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of cerebral ischemia with Fluosol.
    Peerless SJ; Nakamura R; Rodriguez-Salazar A; Hunter IG
    Stroke; 1985; 16(1):38-43. PubMed ID: 3966263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions.
    Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E
    Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.